Matches in Nanopublications for { ?s ?p " RETAVASE is indicated for use in acute ST-elevation myocardial infarction (STEMI) to reduce the risk of death and heart failure. It is also indicated for the use of the drug to reduce risk of heart failure and death. The drug is currently being tested in the US for heart failure, stroke, and stroke, among other cardiovascular conditions, in the U.S. and Canada." ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- assertion wasQuotedFrom " RETAVASE is indicated for use in acute ST-elevation myocardial infarction (STEMI) to reduce the risk of death and heart failure. It is also indicated for the use of the drug to reduce risk of heart failure and death. The drug is currently being tested in the US for heart failure, stroke, and stroke, among other cardiovascular conditions, in the U.S. and Canada." provenance.